Sagittarius Life Science (3205.TWO) Earnings Analysis
Sagittarius Life Science (3205.TWO) has no confirmed upcoming earnings date. Trailing P/E -94.34.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 3205.TWO next report earnings?
No confirmed upcoming earnings date is currently scheduled for 3205.TWO. This page updates as the calendar is published.
3205.TWO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-12-30 | -0.15272 TWD | n/a | n/a | n/a |
| 2025-09-30 | -0.1 TWD | n/a | n/a | n/a |
| 2025-06-30 | -0.33 TWD | n/a | n/a | n/a |
| 2025-05-14 | -0.48 TWD | n/a | n/a | n/a |
| 2025-03-12 | -0.2494 TWD | n/a | n/a | n/a |
3205.TWO valuation and analyst view
| Trailing P/E | -94.34 |
|---|---|
| Trailing EPS | -0.47787 TWD |
| Price / book | 3.20 |
| Dividend yield | 0.00% |
| Market cap | 3.38B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Sagittarius Life Science (3205.TWO)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 3205.TWO. This page updates as the calendar is published.
Did 3205.TWO beat earnings last quarter?
Consensus estimate data was not available for 3205.TWO's 2025-12-30 report.
What is 3205.TWO's current P/E ratio and EPS?
3205.TWO trades at a trailing P/E of -94.34 on trailing EPS of -0.4778653073833797 TWD.
What do analysts rate 3205.TWO?
3205.TWO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.